Voluntary announcement on-market share purchase
Filed with HKEX · Stock code 9926 · · 1 page · English
Summary by 6ix AI
Akeso, Inc. has made a voluntary announcement regarding an on-market share purchase by its trustee. The trustee purchased shares for a total consideration reflecting the company's confidence in its business outlook. This announcement aims to inform shareholders and potential investors about the latest developments within the Group.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Akeso
- Akeso's Gumokimab (IL-17A) Receives NMPA Approval for Active Ankylosing Spondylitis
- Announcement made pursuant to rule 13.10 of the listing rules
- Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2026
- VOLUNTARY ANNOUNCEMENT - HARMONI-GI1 RESULTS PUBLISHED AT 2026 ESMO mOS 14.9m vs 12.1m, HR 0.75 (P=0.0031) FOR IVONESCIMAB PLUS CHEMO VS DURVALUMAB PLUS CHEMO IN 1L ADVANCED BTC
- Akeso Announces Opening of Global Phase II Study of Ivonescimab in First-Line Clear Cell Renal Cell Carcinoma, Including Combination with Cadonilimab
Follow Akeso into a list and get an email when it puts out news.
Follow Akeso